Mettler Toledo (MTD) Stock Price, Fundamentals & Analysis

What MTD does

Mettler Toledo (MTD) manufactures and supplies precision instruments and services worldwide, operating through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments such as balances, pipetting solutions, titrators, pH meters, process analytics sensors, density and refractometry instruments, and thermal analysis systems, as well as analytical instruments including UV/VIS spectrophotometers, moisture analyzers, and cell counters. It also provides industrial instruments comprising weighing instruments, automatic dimensional measurement solutions, vehicle scale systems, industrial software, metal detectors, x-ray systems, checkweighers, and camera-based imaging equipment. Mettler Toledo is part of the S&P 500.

Key numbers explained

• The current price of 1,492.34 USD reflects the latest trading value of a single share.
• The trailing P/E ratio of 32.3 divides the current share price by the last twelve months of earnings per share (46.21 USD), showing how much investors pay for each dollar of recent earnings.
• The forward P/E ratio of 28.9 uses expected future earnings, offering a view of valuation based on analyst estimates.
• A dividend yield of 0% and 0% of earnings paid out as dividends mean the company does not currently distribute cash dividends to shareholders.
• The beta of 1.22 indicates the stock tends to move about 22% more than the overall market, both up and down.
• The 52-week price range of 1,023.05 – 1,525.17 shows the lowest and highest traded prices over the past year, with the current price near the upper end.
• The price-to-book ratio of 2,331.78 compares the market price to the company's book value per share, a figure that can be very high for asset-light or high-margin businesses.
• The debt-to-equity ratio of 16,668.4% expresses total debt as a percentage of shareholders' equity, a metric often used to gauge financial leverage.

Recent news

Recent headlines include a piece noting that one S&P 500 stock is worth attention while two others are ignored, and another highlighting that Goldman Sachs adjusted its price target on Mettler-Toledo to 1,510 from 1,440, keeping a Neutral rating. Other articles ask what makes Mettler-Toledo an attractive bet, profile profitable stocks with competitive advantages, and question whether MTD is underperforming the Nasdaq, while a Q2 teardown compares it with peers in research tools and consumables.

What to watch

Investors typically monitor earnings releases, with the next earnings date set for 5 nov. 2026, as well as revenue growth, which has been 4.5% year over year on trailing twelve-month revenue of 4,13 mld. USD. Profitability metrics such as the 21.9% profit margin and 31.2% operating margin are common focus areas, alongside the company's position among peers like Boston Scientific (BSX), Merck & Co. (MRK), McKesson Corporation (MCK), Abbott Laboratories (ABT), West Pharmaceutical Services (WST), and GE HealthCare (GEHC), as well as broader sector trends in healthcare and diagnostics.